Sorrento Therapeutics (NASDAQ:SRNE) Earns Hold Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report published on Friday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Trading Down 12.8 % Shares of NASDAQ SRNE opened at $0.01 on Friday. Sorrento Therapeutics has a 12 month low of $0.00 and […]
More Stories
SECURITY COUNCIL LIVE: Ukraine President set to brief, as UN chief calls for ‘just peace’
The UN Security Council is due to be briefed by Ukrainian President Volodymyr Zellenskyy in New York on Tuesday as...
CSX Co. (NASDAQ:CSX) Given Average Rating of “Moderate Buy” by Analysts
CSX Co. (NASDAQ:CSX – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the fifteen analysts...
UN’s Guterres urges global solutions as uncertain world edges toward a ‘powder keg’
The world is locked in a “purgatory of polarity” with a growing number of governments and others feeling entitled to...
Arena REIT (ARF) to Issue Interim Dividend of $0.05 on November 6th
Arena REIT (ASX:ARF – Get Free Report) declared a interim dividend on Tuesday, September 24th, MarketIndexAU reports. Investors of record...
Sudan crisis must not be forgotten by world leaders, says UN food agency
Ongoing heavy fighting in Sudan has continued to kill and uproot the country’s people who global leaders should remember as...
US Plans to Bring Attempted Assassination Charge Against Ryan Routh
By Jack Phillips and T.J. Muscaro WEST PALM BEACH, Fla.—Federal prosecutors are looking to bring a charge of attempted assassination...